| Literature DB >> 17853044 |
Fatih Dede1, Birgul Onec, Deniz Ayli, Ipek Isik Gonul, Kursad Onec.
Abstract
Mycophenolate mofetil (MMF) is considered to be a promising therapeutic agent in primary glomerulonephritis but there are no data on the use of MMF in Henoch-Schönlein nephritis (HSN). Herein we report the first adult crescentic HSN patient in whom long-term complete remission was achieved after MMF therapy.Entities:
Mesh：
Substances：
Year: 2008 PMID： 17853044 DOI： 10.1080/00365590701571514
Source DB: PubMed Journal: Scand J Urol Nephrol ISSN： 0036-5599